Sign Up to like & get recommendations! 0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-68647-2
Abstract: Atopic dermatitis (AD) is a chronic disease affecting 10–30% of children and 2–10% of adults worldwide. It is manifested by the pruritus eczema lesions on the skin. Immune thrombocytopenic purpura (ITP) is the most common… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Pediatric Hematology and Oncology"
DOI: 10.1080/08880018.2021.2024928
Abstract: Abstract Primary immune thrombocytopenic purpura (ITP) is an autoimmune disorder with platelet destruction due to B- and T-cell dysregulation and antiplatelet autoantibodies production. Flow cytometry can be used to further characterize the B- and T-cell… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Platelets"
DOI: 10.1080/09537104.2018.1557615
Abstract: Abstract Newborns from mothers with immune thrombocytopenic purpura (ITP) have a risk of thrombocytopenia due to passage of maternal antiplatelet antibodies into fetal/neonatal circulation. We looked for predictors of neonatal thrombocytopenia (nTP) in pregnant women… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Hematology"
DOI: 10.1080/10245332.2017.1365435
Abstract: ABSTRACT Objectives: This study determined the incidence of HPA1, HPA2 and HPA5 polymorphisms in 120 Egyptian immune thrombocytopenic purpura (ITP) patients and 120 healthy Egyptian subjects. Methods: Human platelet antigen (HPA) genotyping was done using… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Hematology"
DOI: 10.1080/10245332.2017.1371479
Abstract: ABSTRACT Background In chronic immune thrombocytopenic purpura (ITP), rituximab removes the harmful autoantibodies through antibody-dependent cellular cytotoxicity. The response to rituximab in ITP is variable; the effectiveness of rituximab is influenced by the process of… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Hematology"
DOI: 10.1080/16078454.2025.2559334
Abstract: ABSTRACT Introduction: Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by thrombocytopenia in the absence of another cause. Our aim is to analyze mortality trends related to ITP in the United States (US) population… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.1080/20009666.2019.1565884
Abstract: ABSTRACT Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by isolated thrombocytopenia (platelet count read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000017608
Abstract: Abstract This study aims to investigate the changes of cytokines and the effect of programmed death ligand 1 (PD-L1) signaling pathway on T cell function in patients with immune thrombocytopenic purpura (ITP). Totally, 40 untreated… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Medicine"
DOI: 10.1097/md.0000000000038587
Abstract: Immune thrombocytopenic purpura (ITP) comprises ~1% to 4% of thrombocytopenia cases during pregnancy. Factors predicting neonatal thrombocytopenia and associated morbidities due to maternal ITP are unclear. The present study aimed to assess the neonatal outcomes… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000000949
Abstract: Wiskott-Aldrich syndrome (WAS) is a rare X-linked immunodeficiency characterized by various clinical phenotypes. We report the case of a 3-year-old immigrant boy presenting with persistent infant-onset thrombocytopenia treated for refractory immune thrombocytopenic purpura. Sequence analysis… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000001543
Abstract: Background: Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by low platelet counts in peripheral blood, impairment of thrombopoiesis in bone marrow, and risk of mild to severe bleedings. ITP can be seen among… read more here.